2017 Full year and fourth quarter
We announced our full year and fourth quarter 2017 results on Wednesday 7 February.
2014 Third Quarter
Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our third quarter 2014 results.
- Q3 2014 results announcement PDF - 698.0KB
- Q3 2014 analyst webcast transcript PDF - 218.1KB
- Q3 2014 launch metrics and pipeline progress PDF - 150.2KB
- Q3 2014 restated finanical Information XLSX - 51.2KB
- Q3 2014 actual growth schedules PDF - 163.4KB
- Q3 2014 US dollar translation PDF - 143.8KB
- Q3 2014 pre announcement aide memoire PDF - 980.8KB
2014 Second Quarter
Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our second quarter 2014 results.
2014 First Quarter
Simon Dingemans, CFO, discusses our first quarter results 2014.
2013 Fourth Quarter - released 05 February 2014
Sir Andrew Witty, CEO, and Simon Dingemans, CFO, discuss our full year 2013 results.
- Q4 2013 results announcement PDF - 272.9KB
- Q4 2013 analyst slide presentation PDF - 2.0MB
- Q4 2013 analyst presentation transcript PDF - 61.3KB
- Q4 2013 analyst investor call transcript PDF - 196.7KB
- Q4 2013 actual growth schedules PDF - 195.2KB
- Q4 2013 US dollar translation PDF - 135.9KB
- Q4 2013 pre announcement aide memoire PDF - 848.7KB
Other key information
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Keep up to date with our news and recent announcements
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business
A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III